Stocks · Healthcare · Medical - Healthcare Information Services
Evolent Health, Inc. EVH
$3.46 +2.06% Close, Oct 2, 2026 · NYSE · Market cap $389.2M
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Over the past year the stock returned -56.9%, behind the S&P 500 by 72.0 percentage points.
- The stock is 58% below its highest close of the past year.
- Revenue over the last four quarters was $2.10B, down 4.5% from a year earlier, accelerating from -21.3% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 24%
- Revenue growth, 3-year CAGRTop 46%
- Revenue growth accelerationTop 9%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 34%
- Gross marginBottom 12%
- Operating marginTop 44%
- Accruals (lower is better)Top 8%
- Interest coverTop 45%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 4%
- Free-cash-flow yieldTop 21%
- EBITDA / enterprise valueBottom 25%
- Sales / enterprise valueTop 5%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 8%
- 6-month returnTop 18%
- 1-year return vs S&P 500Bottom 7%
- Distance from 52-week highBottom 18%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 9%
- Consecutive EPS beatsTop 25%
- Share of analysts rating BuyBottom 50%
- Upside to consensus price targetTop 37%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 16%
- Maximum drawdown, 3 yearsBottom 7%
- Beta vs S&P 500 (lower is better)Top 17%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -21.3% | -4.5% | ↑ |
| Gross margin | 15.3% | 12.9% | ↓ |
| Operating margin | -1.5% | -1.4% | ↑ |
| FCF margin | -2.9% | 0.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -4.5% | -21.3% | ↑ | Bottom 24% |
| Gross margin | 12.9% | 15.3% | ↓ | Bottom 12% |
| Operating margin | -1.4% | -1.5% | ↑ | Top 44% |
| Net margin | -24.1% | -5.9% | ↓ | — |
| Free-cash-flow margin | 0.8% | -2.9% | ↑ | — |
| Return on invested capital | -1.9% | — | Top 34% | |
| Revenue growth, 3-year CAGR | 11.5% | — | Top 46% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -28.3%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +29.7 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -0.4×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 10.74%
- Shareholder yield
- 10.74%
- Share count change, 1 year
- -2.9%
- Share count change, 3-year CAGR
- +0.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- +83.9%
- Average 2-day reaction, last 8
- +2.8%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $7.00
- Target vs current price
- +102.3%
- Analysts with a rating
- 30
- Share rating Buy or Strong Buy
- 77%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +292.1% | +16.6% | +35.4% | +37.3% | — |
| May 7, 2026 | +60.0% | +11.5% | +7.8% | +14.4% | -18.0% |
| Feb 24, 2026 | +33.3% | -7.6% | +29.2% | -10.1% | +40.4% |
| Nov 6, 2025 | -50.0% | -5.5% | -29.9% | -36.9% | -51.3% |
| Aug 7, 2025 | -211.1% | +3.0% | -4.7% | +0.9% | -29.9% |
| May 8, 2025 | -33.3% | +3.2% | -14.4% | -21.6% | -6.5% |
| Feb 20, 2025 | -105.3% | +1.8% | -10.2% | -4.1% | -16.2% |
| Nov 7, 2024 | -86.7% | -0.8% | -48.5% | -54.6% | -58.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $0.02 | -$0.01 | +292.1% | $652.5M |
| May 7, 2026 | -$0.02 | -$0.05 | +60.0% | $496.2M |
| Feb 24, 2026 | $0.08 | $0.06 | +33.3% | $468.7M |
| Nov 6, 2025 | $0.05 | $0.10 | -50.0% | $479.5M |
| Aug 7, 2025 | -$0.10 | $0.09 | -211.1% | $444.3M |
| May 8, 2025 | $0.06 | $0.09 | -33.3% | $483.6M |
| Feb 20, 2025 | -$0.02 | $0.38 | -105.3% | $646.5M |
| Nov 7, 2024 | $0.04 | $0.30 | -86.7% | $621.4M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 20.3× | — | — | — |
| EV / Sales | 0.59× | — | — | Top 5% |
| Free-cash-flow yield | 4.35% | — | — | Top 21% |
| Earnings yield | -129.77% | — | — | Bottom 4% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -15.7%
- 200-day average slope (20 days)
- -0.5%
- Distance from 50-day average
- -13.3%
- Distance from 200-day average
- -9.7%
- RSI (14)
- 34.2
- Relative volume
- 0.74×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 82.4%
- Volatility vs own 5-year history
- 89th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.52
- Correlation with S&P 500
- 0.10
- Current drawdown from 1-year high
- -58.1%
- Maximum drawdown, 3 years
- -93.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 12, 2022 | Mar 30, 2026 | -94.5% | 889 days | Not yet recovered |
| Oct 8, 2021 | Jan 21, 2022 | -35.1% | 72 days | 129 days (Jul 28, 2022) |
| Sep 29, 2020 | Oct 28, 2020 | -22.9% | 21 days | 10 days (Nov 11, 2020) |
| May 3, 2021 | May 10, 2021 | -15.4% | 5 days | 41 days (Jul 8, 2021) |
| Feb 24, 2021 | Mar 4, 2021 | -11.9% | 6 days | 9 days (Mar 17, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $389.2M
- EPS, diluted (TTM)
- -$4.49
- Revenue (TTM)
- $2.10B
- 52-week range
- $2.10 – $8.46
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $908.0M | $1.35B | $1.96B | $2.55B | $1.88B |
| Gross profit | $250.4M | $316.6M | $460.5M | $367.4M | $284.0M |
| Operating income | -$42.4M | $3.6M | -$71.2M | -$40.5M | -$4.4M |
| Net income | -$37.6M | -$19.2M | -$113.0M | -$61.6M | -$534.5M |
| EPS (diluted) | -$0.36 | -$0.20 | -$1.28 | -$0.81 | -$5.07 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $621.4M | $646.5M | $483.6M | $444.3M | $479.5M | $468.7M | $496.2M | $652.5M |
| Net income | -$23.1M | -$22.8M | -$64.6M | -$19.9M | -$20.9M | -$429.1M | -$26.6M | -$28.4M |
| EPS (diluted) | -$0.27 | -$0.27 | -$0.63 | -$0.44 | -$0.24 | -$3.76 | -$0.24 | -$0.25 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $38.7M | -$11.6M | $142.6M | $18.8M | $38.8M |
| Capital expenditure | -$25.0M | -$38.4M | -$28.7M | -$24.9M | -$34.1M |
| Free cash flow | $13.8M | -$49.9M | $113.8M | -$6.1M | $4.8M |
| Dividends paid | -$1.3M | -$14.9M | $0 | -$20.1M | $0 |
| Net share buybacks | $13.3M | $4.5M | $180.5M | $3.5M | -$40.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $115.7M
- Total assets
- $1.97B
- Total liabilities
- $1.59B
- Total debt
- $970.4M
- Net debt
- $854.7M
- Shareholders’ equity
- $383.2M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 14,068,069
- Days to cover
- 5.81
- Change vs previous report
- -9.1%
FINRA short interest, settlement date Sep 15, 2026.